Company:  PASSAGE BIO, INC. (PASG)
Form Type:  4
Filing Date:  3/25/2020 
CIK:  0001787297 
Address:  TWO COMMERCE SQUARE
2001 MARKET STREET, 28TH FLOOR
 
City, State, Zip:  PHILADELPHIA, Pennsylvania 19103 
Telephone:  (267) 866-0312 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$23.67  
Change: 
-0.78 (-3.19%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$1.07B
Trade PASG now with 

© 2020  
Description of Business
We are a genetic medicines company focused on developing transformative therapies for rare, monogenic CNS disorders with limited or no approved treatment options. Our vision is to become the premier genetic medicines company by developing and ultimately commercializing therapies that dramatically and positively transform the lives of patients suffering from these life-threatening disorders. To achieve our vision, we have assembled a world-class team whose members have decades of collective experience in genetic medicines and rare disease drug development and commercialization. The field of genetic medicine is rapidly expanding and we believe we have a differentiated approach to developing treatments for rare, monogenic CNS disorders that enables us to select and advance product candidates with a higher probability of technical and regulatory success. We have entered into a strategic research collaboration with Penn's GTP, headed by Dr.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES